Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CETP | P11597 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | UBE2N | P61088 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28335927 | 0.97 | TRPV1 (0.50) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL15509789 | 0.97 | TRPV1 (0.50) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL6169557 | 0.97 | TRPV1 (0.50) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL28870509 | 0.97 | TRPV1 (0.44) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL8532467 | 0.92 | — | — | |
| SCHEMBL31501273 | 0.85 | TRPV1 (0.60) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL8412963 | 0.85 | PTPN1 (0.39) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL15484265 | 0.83 | TRPV1 (0.46) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL5127737 | 0.82 | TRPV1 (0.48) | TRPV1TRPA1SPHK1LMNACYP2D6 | |
| SCHEMBL3399170 | 0.82 | TRPV1 (0.41) | TRPV1TRPA1SPHK1LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2816096-B1 | METHOD AND APPARATUS FOR STORING EXCESS ENERGY | EVONIK OPERATIONS GMBH (DE) | 2021-05-12 | — | — | EP | claimed |
| EP-2816096-A1 | Method for storing excess energy | Evonik Industries AG (DE) | 2014-12-24 | — | — | EP | claimed |
| WO-2004106281-A1 | CRYSTALLINE GABAPENTIN | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | WO | claimed |
| CN-1110541-C | Concentrated water-dispersible stable fiber softener compositions | PROCTER & GAMBLE (US) | 2003-06-04 | — | — | CN | claimed |
| CN-1219953-A | Fabric softening compound/composition | PROCTER & GAMBLE (US) | 1999-06-16 | — | — | CN | claimed |
| CN-1196081-A | Concentrated, water dispersible, stable, fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-14 | — | — | CN | claimed |
| CN-1195369-A | Concentrated and stable fabric softening compositions | PROCTER & GAMBLE (US) | 1998-10-07 | — | — | CN | claimed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0839179-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-06 | — | — | EP | claimed |
| WO-1998017756-A1 | CONCENTRATED FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-30 | — | — | WO | claimed |
| WO-1997003170-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | claimed |
| US-12522619-B2 | Inhibitors of complement factors and uses thereof | ANNEXON, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| EP-4463462-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | Annexon, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-118715231-A | Complement factor inhibitors and uses thereof | 安尼艾克松股份有限公司 | 2024-09-27 | — | — | CN | disclosed |
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON, INC. | 2023-08-24 | — | — | US | disclosed |
| US-4931537-A | CURABLE EPOXY SYSTEMS; HYDROXY-FUNCTIONAL GLYCIDAMIDES FROM AMINO RESINS; SOLVENT, WEATHER RESISTANT | MONSANTO COMPANY (US) | 1990-06-05 | — | — | US | disclosed |
| US-4931536-A | PRECURSORS FOR EPOXIDIZED ANINO RESINS; METHYLOLATING CYCLIC UREA OR MELAMINE COMPONENTS, ETHERIFICATION, ACRYLAMIDATION, TRANSETHERIFICATION, EPOXIDATION | MONSANTO COMPANY (US) | 1990-06-05 | — | — | US | disclosed |
| EP-0345240-A2 | Hydroxy functional acrylamidomethyl amino resins and hydroxy functional glycidamidomethyl amino resins | MONSANTO COMPANY (US) | 1989-12-06 | — | — | EP | disclosed |
| EP-0344144-A2 | Polyglycidamide coating compositions | MONSANTO COMPANY (US) | 1989-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265109-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFB, CFH, C9 | TRPV1 3867/4885TRPA1 2579/4885SPHK1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.